Skimming for Outperformers
On days like Wednesday, in addition to tracking inverse ETFs that could offer opportunity to capture some gains from the market's downside trade, I also monitor which stocks are bucking the trend and notching gains.
One low-priced name that I've had on a watch list for about a week is SciClone Pharmaceuticals (SCLN), which advanced Wednesday as the market declined. On Tuesday, the company said it would increase its share-repurchase program. That likely helped spur price gains on a day when the wider market melted down....464 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.